Research Applications

• Intestinal inflammation and mucosal healing
• IBD and IBS-adjacent gut permeability research
• Systemic inflammatory modulation
• Wound healing and skin barrier research
• Cellular stress response

Mechanism

KPV binds to the melanocortin-1 receptor (MC1R) and intracellular receptors on epithelial and immune cells. Oral capsule delivery allows direct exposure to intestinal tissue, making it particularly relevant for gut-targeted protocols. Research suggests oral bioavailability is favorable for intestinal applications compared to injectable routes, as the peptide reaches the gut lumen directly before systemic absorption.

Presented For

Research into inflammatory bowel conditions, mucosal repair, and systemic anti-inflammatory pathways. Often paired with BPC-157 in gut-focused protocols.

For research purposes only. Not intended for human use.